Latest New Zealand News

Gryphon Capital Income Trust (ASX:GCI) has announced a $90.9 million wholesale placement of new units priced at $2.00 each, aiming to bolster its portfolio management capabilities. The placement leverages existing capacity, avoiding the need for unitholder approval.

JCurve Solutions has reported a strong half-year performance, returning to profitability with a 32% increase in revenue to $7.02 million, driven by higher NetSuite commissions and a strategic shift towards larger customers.

A recent expert panel convened by Novitas has strongly endorsed Pacific Edge’s urine-based Cxbladder tests for hematuria evaluation, recommending Medicare coverage based on robust clinical evidence and patient care benefits.

Adairs Limited reported a solid 5.9% increase in sales for the half year ended December 2025, driven by strong brand performances, especially Mocka. However, underlying EBIT declined 9.1% due to margin pressures and rising costs, while the company declared a fully franked interim dividend.

Kogan.com Ltd has delivered a robust half-year performance with strong revenue growth and margin expansion, while Mighty Ape embarks on a strategic reset aiming for profitability in the second half of FY26.

EVT Limited reported a robust first half for 2026 with revenue rising 5.4% to A$683.8 million and net profit up 21.6%, driven by strong performances in Germany, Thredbo, and Hotels. Strategic acquisitions, including Pro-invest Hotels and QT Auckland, underpin the group’s growth ambitions.

Pharmx Technologies has entered a multi-year strategic alliance with Sigma Healthcare, becoming the preferred EDI provider for Sigma and Chemist Warehouse across Australia and New Zealand, while Sigma takes a significant equity stake.

nib holdings limited reported a stable net profit of $82.9 million for the half year ended 31 December 2025, supported by 6% revenue growth and disciplined expense management. The Board declared a fully franked interim dividend of 13.0 cents per share.

Critical Resources Limited has identified three priority targets at its Lammerlaw Gold Project in New Zealand, validating the area’s gold potential ahead of permit approval and outlining a cost-effective exploration strategy.

Biome Australia Limited has reported a robust half-year performance, with revenues climbing nearly 40% and net profit more than doubling, driven by strong product momentum and strategic investments.

Reece Limited reported a 6% rise in sales revenue to $4.6 billion for the half-year ending December 2025, while profits declined amid challenging market conditions. The company continues to expand its branch network in Australia and the US, balancing growth ambitions with cost pressures.

thl reports an 11% rise in underlying NPAT for H1 FY26 and sets a bullish FY26 guidance, underpinned by strategic divestments and cost efficiencies.